A new hope? Lymphoma Drug Wakes Up Dormant HIV
Mar 22, 2009
A drug approved to treat lymphoma, Zolinza (vorinostat, SAHA) can wake up CD4 cells latently infected with HIV and render them vulnerable to antiretroviral (ARV) medication, according to a study published in the Journal of Biological Chemistry and reported by EurekAlert. Activating these dormant cells is a goal for researchers who hope to find ways to either eradicate the virus or help the body control HIV infection without ARV therapy.
Could be a new hope for us. Any thoughts?
Response from Dr. Holodniy
Perhaps. But more studies will have to be done in HIV infected people to determine whether this is a safe strategy.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.